Literature DB >> 2032720

Primary structure of the goat beta-globin locus control region.

Q Li1, B Zhou, P Powers, T Enver, G Stamatoyannopoulos.   

Abstract

The goat beta-globin cluster is composed of a triplicated four-gene set. A locus control region (LCR) containing elements homologous to 5'DNase I hypersensitive sites (HS) 1, 2, and 3 of the human beta-globin LCR has been identified at the 5' end of this locus. We determined 10.2 kb of nucleotide sequence from the goat beta-globin locus control region. Self-comparison of this sequence by dot matrix analysis revealed the presence of six complete and three incomplete artiodactyl repeats. A novel repeated element, termed D repeat, was also identified. Southern blotting analysis demonstrated that these elements exist in the goat genome as a low to medium frequency interspersed repeat family. The absence of any other large region of self-homology (direct or inverted) in the goat LCR suggests that 5'HSs 1, 2, and 3 did not arise through duplication, but rather evolved independently. By comparing goat 5'HS 1 to those of human, rabbit, and mouse, we show a greater than 80% conservation in sequence between the four species. This level of evolutionary conservation suggests that 5'HS 1 plays an important role in the regulation of beta-globin loci.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2032720     DOI: 10.1016/0888-7543(91)90415-b

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  10 in total

Review 1.  Towards a comprehensive catalogue of validated and target-linked human enhancers.

Authors:  Molly Gasperini; Jacob M Tome; Jay Shendure
Journal:  Nat Rev Genet       Date:  2020-01-27       Impact factor: 53.242

2.  Comparative analysis of the locus control region of the rabbit beta-like gene cluster: HS3 increases transient expression of an embryonic epsilon-globin gene.

Authors:  R Hardison; J Xu; J Jackson; J Mansberger; O Selifonova; B Grotch; J Biesecker; H Petrykowska; W Miller
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

3.  Role of gene order in developmental control of human gamma- and beta-globin gene expression.

Authors:  K R Peterson; G Stamatoyannopoulos
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

4.  Characterization of the cow stomach lysozyme genes: repetitive DNA and concerted evolution.

Authors:  D M Irwin; R T White; A C Wilson
Journal:  J Mol Evol       Date:  1993-10       Impact factor: 2.395

5.  Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3.

Authors:  B A Hug; R L Wesselschmidt; S Fiering; M A Bender; E Epner; M Groudine; T J Ley
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

6.  Multiple elements in human beta-globin locus control region 5' HS 2 are involved in enhancer activity and position-independent, transgene expression.

Authors:  J J Caterina; D J Ciavatta; D Donze; R R Behringer; T M Townes
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

7.  A single beta-globin locus control region element (5' hypersensitive site 2) is sufficient for developmental regulation of human globin genes in transgenic mice.

Authors:  B J Morley; C A Abbott; J A Sharpe; J Lida; P S Chan-Thomas; W G Wood
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

8.  The mouse beta-globin locus control region: hypersensitive sites 3 and 4.

Authors:  G Jiménez; K B Gale; T Enver
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

9.  Structure and function of the murine beta-globin locus control region 5' HS-3.

Authors:  B A Hug; A M Moon; T J Ley
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

10.  Activation of the beta-globin locus control region precedes commitment to the erythroid lineage.

Authors:  G Jiménez; S D Griffiths; A M Ford; M F Greaves; T Enver
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.